HER -2/neu gene amplification and protein expression by fluorescence in situ hybridization analysis with a tissue microarray

Keywords

Breast cancer, Tissue microarray, Fluorescence in situ hybridization, Immunohistochemistry, Biology

References

No references recorded for this paper.

Cited by

No citing papers recorded for this paper.

Related papers

• Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization.Diane L. Persons, K A Borelli, Ping H. Hsu — 1997
• TOP2A amplification in the absence of that of HER-2/neu: toward individualization of chemotherapeutic practice in breast cancer.Ronan W. Glynn, Sarah Mahon, Catherine Curran — 2011
• [Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].Zhi-Yong Liang, Wenze Wang, Jie Gao — 2007
• Correlation of detecting HER-2 gene amplification and HER-2 protein expression in breast cancerYinyin Fan — 2011
• A modified approach for I-FISH evaluation of ERBB2 (HER-2) gene copy numbers in breast carcinomas: comparison with HER-2/CEP17 ratio systemMarcela Mrhalová, Roman Kodet — 2007
• Strong HER-2/neu protein overexpression by immunohistochemistry often does not predict oncogene amplification by fluorescence in situ hybridization.Lauren Hammock, Melinda M. Lewis, Carol N. Phillips — 2003
• Amplification of the HER‐2/neu oncogene is uncommon in pediatric osteosarcomasAnirban Maitra, Dana Wanzer, Arthur G. Weinberg — 2001
• [gene amplification as a mechanism of clonal heterogeneity in breast cancer].Ю. А. Павленко, Л Э Завалишина, П. Е. Повилайтите — 2019